About this content About Jamie Ashcroft Jamie Ashcroft, the News Editor for Proactive UK, has developed an impressive career in financial journalism, focusing on the small-cap sector for over fourteen years. Before joining the Proactive team, he was a stockbroker during the global financial crisis, a role that complemented his educational background - a first-class degree in Business and Economics and qualifications in software design and development. As one of the early external hires at Proactive in 20 ...

Best Buy's Leaner Cost Structure Drives Post-Earnings Rally - 24/7 Wall St.[S&P 5006,772.40 -1.50%] [Dow Jones48,038.40 -1.69%][Nasdaq 10024,530.70 -1.72%][Russell 20002,578.94 -2.71%][FTSE 10010,465.80 -3.11%][Nikkei 22554,206.20 -5.78%][Stock Market Live March 3, 2026: S&P 500 (SPY) Down Big on Iran War Fears][Investing]# Best Buy's Leaner Cost Structure Drives Post-Earnings Rally### Quick ReadBest Buy (BBY) beat Q4 EPS estimates at $2.61 but revenue of $13.8B missed by $66M.Best Buy guided FY27 comparabl ...

LONDON--(BUSINESS WIRE)--Morningstar Sustainalytics, part of Morningstar, Inc. (Nasdaq: MORN), a leading global provider of ESG data, research, and ratings, today released findings from its inaugural State of ESG Data Survey, revealing a financial industry increasingly dependent on actionable sustainability information. Morningstar Sustainalytics clients surveyed cited ongoing challenges around data quality and coverage, increased demand for regulatory-aligned insights and a shift toward forwar. ...

Core Viewpoint - Hesai Group has successfully adopted all proposed resolutions during the extraordinary general meetings held in Suzhou, China, which includes significant corporate actions and amendments to its articles of association [1][2]. Group 1: Corporate Actions - 50,000,000 authorized, unissued, and undesignated shares have been re-designated as Class B ordinary shares on a one-for-one basis [2]. - The existing memorandum and articles of association have been amended and restated, replacing them entirely with a new version as outlined in the circular dated January 26, 2026 [2]. - The directors have been granted a general unconditional mandate to allot, issue, and deal with additional Class B ordinary shares or equivalents [2]. - The directors have also received a general unconditional mandate to repurchase the Company's own shares and/or American depositary shares under specified terms and periods [2]. Group 2: Company Overview - Hesai Technology is recognized as a global leader in lidar solutions, catering to a wide range of applications including advanced driver-assistance systems (ADAS), autonomous vehicles, and robotics [3]. - The Company integrates its in-house manufacturing with lidar research and development, allowing for rapid product iteration while maintaining high performance and affordability [3]. - Hesai has established a presence in major locations including Shanghai, Palo Alto, and Stuttgart, serving customers across more than 40 countries [3].

JPMorgan (NYSE:JPM) CEO Jamie Dimon warned Monday that the next credit cycle will be “worse than a normal one” due to widespread complacency among lenders.Speaking at JPMorgan’s Global Leveraged Finance Conference in Miami Beach, Dimon said individuals and corporations are in good shape, but governments “have far more debt than they’ve ever had before.”“Asset prices are very high. Credit spreads are very low,” he said. “I don’t think a lot of people have seen a credit cycle. Not everyone who makes loans is ...

Core Viewpoint - Modular Medical, Inc. has announced a public offering of 68,098,000 shares of its common stock and warrants, targeting adult "almost-pumpers" with its FDA-cleared insulin delivery technology [1] Group 1: Company Overview - Modular Medical specializes in insulin delivery technology and has developed the first FDA-cleared patch pump designed for adult users [1] - The company aims to provide a user-friendly and affordable solution for insulin delivery [1] Group 2: Public Offering Details - The public offering includes 68,098,000 shares of common stock and warrants to purchase an equal number of shares at a combined price of $0.1762 per share [1] - The warrants will have an exercise price of $0.1762 per share, are immediately exercisable, and will expire five years from the issuance date [1]

BigBear.AI Inc (NYSE:BBAI) reported mixed financial results for the fourth quarter Monday after the close.BigBear.AI reported fourth-quarter revenue of $27.3 million, missing analyst estimates of $33.31 million, according to Benzinga Pro. The company reported a quarterly loss of one cent per share, beating expectations for a loss of six cents per share."At the start of 2025, we set out to transform our financial foundations to establish a base from which to accelerate in 2026. We have delivered exactly that ...

Core Insights - SOPHiA GENETICS S.A. reported a strong Q3 performance with a 23% year-over-year revenue growth, driven by new customer signings and expansion within existing accounts [4][27][40] - The company raised its 2025 revenue guidance to a range of $75 million to $77 million, reflecting confidence in continued growth momentum [3][36] Customer Growth and Expansion - In Q3, SOPHiA signed 31 new customers, bringing the total for 2025 to 94, surpassing the previous year's total of 92 [3][17] - The company successfully expanded its offerings at existing institutions, including major deals with Gustave Roussy and New South Wales Pathology [2][5] Market Performance - U.S. revenue grew by 30% year-over-year, contributing significantly to overall growth [1][15] - EMEA region saw a 24% revenue growth, with notable contributions from the UK and Belgium, which grew by 120% and 70% respectively [14][15] Product Development and Innovation - The company highlighted the success of its liquid biopsy application, MSK Access, which is gaining traction among customers [5][7] - SOPHiA introduced a new technology called SOPHiA DDM Digital Twins, aimed at enhancing treatment decision-making for oncologists [9][10] Financial Performance - Total revenue for Q3 was $19.5 million, compared to $15.9 million in the same quarter last year, with gross profit increasing to $12.9 million [27][29] - Adjusted gross margin remained strong at 73.1%, despite a significant increase in data processed by the platform [11][29] Strategic Partnerships - The partnership with AstraZeneca is expected to enhance market access for liquid biopsy testing and contribute to drug development [7][21] - Collaborations with Myriad Genetics and ADAM Innovations are aimed at developing regulated companion diagnostics in the U.S. and Japan [7][21][63] Future Outlook - The company anticipates continued growth in 2026, driven by strong customer demand and the successful implementation of new applications [36][70] - SOPHiA is focused on optimizing costs while expanding its customer base and product offerings [12][38]

Core Insights - First Solar Inc. (FSLR) shares fell 12.7% in after-hours trading on February 24, 2026, following mixed fourth-quarter 2025 results, missing earnings expectations while beating revenue estimates [1][5] - The company's revenue guidance for 2026 is below Wall Street estimates, indicating potential challenges ahead [1][7] Financial Performance - FSLR's fourth-quarter 2025 earnings missed the Zacks Consensus Estimate by 7.3%, while revenues exceeded the consensus by 7% [5] - Year-over-year, both top and bottom lines improved by double-digit percentages, driven by a significant increase in solar module sales volume [5] - The company reported a net cash balance of $2.4 billion, an increase of $0.9 billion from the previous quarter [6] Guidance and Market Conditions - FSLR expects revenues of $4.9-$5.2 billion in 2026, with the lower end reflecting a 5.8% year-over-year decline [7] - The company anticipates a financial impact of up to $135 million in 2026 due to new tariffs and is idling Southeast Asian factories to adapt to the trade environment [8] ETFs Exposure - Invesco Solar ETF (TAN) holds 6.69% of FSLR and has gained 14.7% year to date, charging 70 basis points in fees [10] - Virtus Duff & Phelps Clean Energy ETF (VCLN) includes FSLR at 5.69% of its holdings, with a year-to-date increase of 10.9% and fees of 59 basis points [11] - iShares Global Clean Energy ETF (ICLN) features FSLR at 6.06% of the fund, rising 11.6% year to date with fees of 39 basis points [12] - Global X CleanTech ETF (CTEC) has FSLR at 4.49% of its holdings, with an 11.3% year-to-date increase and fees of 50 basis points [13]

Financial Performance - Netlist, Inc. reported a quarterly loss of $0.01 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.05 per share a year ago [1] - The company posted revenues of $75.72 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 72.08%, and up from $34.28 million year-over-year [2] - Over the last four quarters, Netlist has consistently surpassed consensus revenue estimates [2] Stock Performance - Netlist shares have increased approximately 39.7% since the beginning of the year, significantly outperforming the S&P 500, which gained only 0.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.01 on revenues of $40 million, and for the current fiscal year, it is -$0.04 on revenues of $166 million [7] - The estimate revisions trend for Netlist was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Computer-Storage Devices industry, to which Netlist belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]